CBD Life Sciences Inc.

OTCPK:CBDL Stock Report

Market Cap: US$1.3m

CBD Life Sciences Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Lisa Nelson

Chief executive officer

US$120.0k

Total compensation

CEO salary percentage100.0%
CEO tenure5.9yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure7yrs

Recent management updates

No updates

Recent updates

CEO Compensation Analysis

How has Lisa Nelson's remuneration changed compared to CBD Life Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

-US$107k

Dec 31 2023US$120kUS$120k

-US$79k

Mar 31 2023n/an/a

-US$600k

Dec 31 2022US$120kn/a

-US$860k

Jun 30 2022n/an/a

-US$3m

Mar 31 2022n/an/a

-US$5m

Dec 31 2021US$240kUS$240k

-US$6m

Sep 30 2021n/an/a

-US$5m

Dec 31 2020US$240kUS$240k

-US$2m

Sep 30 2020n/an/a

-US$2m

Dec 31 2019US$97kn/a

-US$861k

Compensation vs Market: Lisa's total compensation ($USD120.00K) is below average for companies of similar size in the US market ($USD649.63K).

Compensation vs Earnings: Lisa's compensation has been consistent with company performance over the past year.

CEO

Lisa Nelson (57 yo)

5.9yrs

Tenure

US$120,000

Compensation

Mrs. Lisa Anne Nelson serves as Chief Executive Officer, President, Chief Financial Officer, Secretary, Treasurer at FBC Holding, Inc. since 2022. She serves as Director FBC Holding, Inc. She has been the...

Board Members

NamePositionTenureCompensationOwnership
Lisa Nelson
CEO, President5.9yrsUS$120.00kno data
Brianna Nelson
Chief Product Developer & Directorno datano datano data
Susan Lehrer
Member of Advisory Board7.1yrsno datano data
Mark Beesley
Member of Advisory Board6.9yrsno datano data
Mark Anderson
Member of Advisory Board7.1yrsno datano data
Cory Jammal
Member of Advisory Board7.1yrsno datano data
Michael Russell
Member of Advisory Board6.6yrsno datano data

7.0yrs

Average Tenure

Experienced Board: CBDL's board of directors are considered experienced (7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/31 22:24
End of Day Share Price 2024/12/31 00:00
Earnings2024/03/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CBD Life Sciences Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution